EXHIBIT 10.25 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this "AGREEMENT), is made and entered into as of the 1st day of December, 1999 (the "EFFECTIVE DATE"), by and between INTERLEUKIN GENETICS, INC., a Texas corporation ("EMPLOYER"), and...Employment Agreement • April 14th, 2000 • Interleukin Genetics Inc • Services-medical laboratories • Texas
Contract Type FiledApril 14th, 2000 Company Industry Jurisdiction
2 3 Section 6. Mutilated or Missing Warrants. In case this Warrant shall be mutilated, lost, stolen, or destroyed, the Company shall issue in exchange and substitution of and upon cancellation of the mutilated Warrant, or in lieu of and substitution...Interleukin Genetics Inc • March 7th, 2001 • Services-medical laboratories • New York
Company FiledMarch 7th, 2001 Industry Jurisdiction
2- 3 Common Stock issued to such Investor. Such Registration Statement also shall cover, to the extent allowable under the 1933 Act and the Rules promulgated thereunder (including Rule 416), such indeterminate number of additional shares of Common...Registration Rights Agreement • March 7th, 2001 • Interleukin Genetics Inc • Services-medical laboratories • New York
Contract Type FiledMarch 7th, 2001 Company Industry Jurisdiction
OF DIGISPHERE, LLCOperating Agreement • October 29th, 1997 • Medical Science Systems Inc • Services-medical laboratories • Delaware
Contract Type FiledOctober 29th, 1997 Company Industry Jurisdiction
1 EXHIBIT 4.4 SECURITY AGREEMENT THIS SECURITY AGREEMENT is entered into as of the 19th day of August, 1997 by and between Medical Science Systems, Inc., a Texas corporation (the "Borrower") and (the "Secured Party"). 1. Creation of Security Interest....Security Agreement • October 8th, 1997 • Medical Science Systems Inc • California
Contract Type FiledOctober 8th, 1997 Company Jurisdiction
EXHIBIT 10.05 AMENDMENT NO. 2 TO NOTE PURCHASE AGREEMENT THIS AMENDMENT NO. 2 (the "AMENDMENT"), dated as of January 28, 2003, is by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (the "COMPANY"), and PYXIS INNOVATIONS INC., a Delaware...Note Purchase Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
Contract Type FiledMarch 5th, 2003 Company Industry
EXHIBIT 10.1 STOCK PURCHASE AGREEMENTStock Purchase Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledMarch 5th, 2003 Company Industry Jurisdiction
1 EXHIBIT 4.2 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "ACT") OR ANY STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED...Medical Science Systems Inc • November 21st, 1997 • Services-medical laboratories • Connecticut
Company FiledNovember 21st, 1997 Industry Jurisdiction
EXHIBIT 10.3 AMENDMENT NO. 2 TO SECURITY AGREEMENT THIS AMENDMENT NO. 2 (the "AMENDMENT"), dated as of March 5, 2003, is by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (the "COMPANY"), and PYXIS INNOVATIONS INC., a Delaware...Security Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
Contract Type FiledMarch 5th, 2003 Company Industry
OFFICE LEASE ONE INTERNATIONAL CENTREOffice Lease • October 8th, 1997 • Medical Science Systems Inc • Texas
Contract Type FiledOctober 8th, 1997 Company Jurisdiction
COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • March 5th, 2010 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
Contract Type FiledMarch 5th, 2010 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the 5 year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Interleukin Genetics, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
RECITALSPurchase Agreement • March 7th, 2001 • Interleukin Genetics Inc • Services-medical laboratories • New York
Contract Type FiledMarch 7th, 2001 Company Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 5th, 2010 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMarch 5th, 2010 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 5, 2010, between Interleukin Genetics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
BUSINESS LINE |X| BUSINESS LOAN AGREEMENT To: Bank of America National Trust and Savings Association Business Lending Services #1738 101 S. Marengo Avenue, 5th Floor Pasadena, CA 91122 CUSTOMER NAME MEDICAL SCIENCE SYSTEMS, INC. LINE OF CREDIT/LOAN...Medical Science Systems Inc • May 17th, 1999 • Services-medical laboratories • California
Company FiledMay 17th, 1999 Industry Jurisdiction
EXHIBIT 10.8 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (the "AGREEMENT") is made as of March 5, 2003, by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (the "COMPANY"), and PYXIS INNOVATIONS INC., a Delaware...Registration Rights Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledMarch 5th, 2003 Company Industry Jurisdiction
LEASEMedical Science Systems Inc • October 8th, 1997
Company FiledOctober 8th, 1997
November 9, 1994Medical Science Systems Inc • October 29th, 1997 • Services-medical laboratories
Company FiledOctober 29th, 1997 Industry
EXHIBIT 10.26 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (this "AGREEMENT), is made and entered into as of the 1st day of April, 2000 (the "EFFECTIVE DATE"), by and between INTERLEUKIN GENETICS, INC., a Texas corporation ("EMPLOYER"), and PHILIP...Employment Agreement • April 14th, 2000 • Interleukin Genetics Inc • Services-medical laboratories • Texas
Contract Type FiledApril 14th, 2000 Company Industry Jurisdiction
RECITALSPurchase Agreement • March 7th, 2001 • Interleukin Genetics Inc • Services-medical laboratories • New York
Contract Type FiledMarch 7th, 2001 Company Industry Jurisdiction
EXHIBIT 10.7 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT ("Agreement"), by and between Medical Science Systems, Inc., a Texas Corporation (the "Corporation"), and Paul J. White ("Employee"), is effective this 1st day of January, 1996 ("Effective...Employment Agreement • October 8th, 1997 • Medical Science Systems Inc
Contract Type FiledOctober 8th, 1997 Company
1 2 interests; provided, however, that Employee is not precluded from devoting reasonable periods to time required: (i) for serving as a director or committee member of any organization that does not compete with Employer or that does not involve a...Employment Agreement • March 26th, 2001 • Interleukin Genetics Inc • Services-medical laboratories • Massachusetts
Contract Type FiledMarch 26th, 2001 Company Industry Jurisdiction
LOGO] BANK OF AMERICA =============================================================================== TO: Bank of America National Trust and Savings Association BUSINESS LOAN AGREEMENT-FIXED RATE Unit No. 1737 SECURED BY PERSONAL PROPERTY...Agreement • October 8th, 1997 • Medical Science Systems Inc • California
Contract Type FiledOctober 8th, 1997 Company Jurisdiction
EXHIBIT 10-34 COMMERCIAL LEASE 1. PARTIES: CLEMATIS LLC, with a principal place of business at 411 Waverley Oaks Road, Suite 340, Waltham, MA, 02452, LESSOR, which expression shall include its heirs, successors, and assigns where the context so...Interleukin Genetics Inc • March 28th, 2002 • In vitro & in vivo diagnostic substances
Company FiledMarch 28th, 2002 Industry
2- 3 covering the resale of the Additional Registrable Securities in an amount equal to the number of shares of Common Stock issued to such Investor. Such Registration Statement also shall cover, to the extent allowable under the 1933 Act and the...Registration Rights Agreement • March 7th, 2001 • Interleukin Genetics Inc • Services-medical laboratories • New York
Contract Type FiledMarch 7th, 2001 Company Industry Jurisdiction
CONFIDENTIALInterleukin Genetics Inc • March 5th, 2010 • In vitro & in vivo diagnostic substances • New York
Company FiledMarch 5th, 2010 Industry Jurisdiction
EXHIBIT 10.10 AMENDMENT TO EMPLOYMENT AGREEMENT THIS AMENDMENT (the "AMENDMENT"), dated as of March 5, 2003, is made by and between INTERLEUKIN GENETICS, INC., a Delaware corporation ("EMPLOYER"), and FENEL ELOI, an individual ("EMPLOYEE"). Employer...Employment Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
Contract Type FiledMarch 5th, 2003 Company Industry
AMENDMENT TO EMPLOYMENT AGREEMENT THIS AMENDMENT TO EMPLOYMENT AGREEMENT (the "Amendment"), by and between Medical Science Systems, Inc., a Texas Corporation (the "Corporation"), and Dr. Kenneth S. Kornman ("Employee"), is effective this 17th day of...Employment Agreement • March 31st, 1999 • Medical Science Systems Inc • Services-medical laboratories
Contract Type FiledMarch 31st, 1999 Company Industry
EXHIBIT 10.12 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT THIS AMENDMENT NO. 1 (the "AMENDMENT"), dated as of March 5, 2003, is made by and between INTERLEUKIN GENETICS, INC., a Delaware corporation ("EMPLOYER"), and PAUL MARTHA, M.D., an individual...Employment Agreement • March 5th, 2003 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
Contract Type FiledMarch 5th, 2003 Company Industry
2- 3 7. The Company and Tail Wind agree that Section 7.3 of the Purchase Agreement shall be deleted in its entirety and replaced and superseded with the following Section 7.3:Agreement • March 7th, 2001 • Interleukin Genetics Inc • Services-medical laboratories
Contract Type FiledMarch 7th, 2001 Company Industry
PARTICIPANT: _________________ SOCIAL SECURITY NUMBER: _________________ ADDRESS: _________________ _________________ TOTAL OPTION SHARES: _________________ EXERCISE PRICE PER SHARE: _________________ DATE OF GRANT: _________________ FIRST VESTING...Form of Stock Option Agreement • October 8th, 1997 • Medical Science Systems Inc • California
Contract Type FiledOctober 8th, 1997 Company Jurisdiction
1 EXHIBIT 4.7 [BANK OF AMERICA LOGO] =============================================================================== [ ] Business Line [X] Business Loan Agreement Secured TO: Bank of America National Trust and Savings Association Business Lending...Agreement • October 8th, 1997 • Medical Science Systems Inc • California
Contract Type FiledOctober 8th, 1997 Company Jurisdiction
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 1st, 2016 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
Contract Type FiledAugust 1st, 2016 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of July 29, 2016, between Interleukin Genetics, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
2 3 Section 6. Mutilated or Missing Warrants. In case this Warrant shall be mutilated, lost, stolen, or destroyed, the Company shall issue in exchange and substitution of and upon cancellation of the mutilated Warrant, or in lieu of and substitution...Interleukin Genetics Inc • March 7th, 2001 • Services-medical laboratories • New York
Company FiledMarch 7th, 2001 Industry Jurisdiction
EXHIBIT 10.3 MEDICAL SCIENCE SYSTEMS, INC. SUBSCRIPTION AGREEMENT made as of this ____ day of ________, 1999 between Medical Science Systems, Inc., a Texas corporation with its principal offices at 100 N.E. Loop 410, Suite 820, San Antonio, Texas...Subscription Agreement • August 16th, 1999 • Medical Science Systems Inc • Services-medical laboratories • New York
Contract Type FiledAugust 16th, 1999 Company Industry Jurisdiction
ContractInterleukin Genetics Inc • April 17th, 2017 • In vitro & in vivo diagnostic substances • Delaware
Company FiledApril 17th, 2017 Industry JurisdictionTHIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THIS WARRANT.